Cover Image
市場調查報告書

人類血漿製治療藥市場產品及開發平台分析

A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

出版商 Frost & Sullivan 商品編碼 346561
出版日期 內容資訊 英文 61 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
人類血漿製治療藥市場產品及開發平台分析 A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market
出版日期: 2015年12月08日 內容資訊: 英文 61 Pages
簡介

全球人類血漿製治療藥市場由於對治療方法的意識提升等因素,預測其需求將擴大。對新免疫球蛋白產品與治療方法的意識提升,更帶動了市場將呈兩位數成長。

本報告提供全球人類血漿製治療藥市場相關調查,提供您已上市產品及開發中產品的競爭趨勢,並彙整市場推動因素與課題等資料。

第1章 摘要整理

第2章 調查方法與調查範圍

第3章 市場背景

  • 市場區隔
  • 市場預測

第4章 競爭環境

  • 已上市產品
  • 開發中產品
  • 產品數
  • 臨床實驗趨勢

第5章 已上市產品分析

  • 白蛋白
  • 凝血因子
  • 免疫球蛋白

第6章 開發中產品分析

  • 已通過核准
  • 第三階段
  • 第二階段
  • 第一階段

第7章 產品開發動態即時看板系統

  • ResusixTM, Entegrion, Inc.
  • CINRYZER, Shire
  • BIOSTATER, CSL Behring
  • Gammagard, Baxter

第8章 結論及建議

  • 結論及建議
  • 法律上的免責聲明

第9章 附錄

第10章 Frost & SUllican案例

目錄
Product Code: MAEC-01-00-00-00

Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth

The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting information on clinical trial timelines and results and historical and projected launch timelines. The report also focuses on the competitive landscape of both marketed and pipeline products and provides the market drivers and challenges.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Executive Summary
  • 2. Recent Market Developments
  • 3. Key M&As and Partnership Assessment
  • 4. Companies to Watch

2. METHODOLOGY AND SCOPE

Methodology and Scope

  • 1. Methodology and Scope

3. MARKET BACKGROUND

Market Background

  • 1. Market Background-Segmentation
  • 2. Market Background-Segmentation (continued)
  • 3. Market Background-Segmentation (continued)
  • 4. Market Segmentation
  • 5. Market Segmentation (continued)
  • 6. Market Forecasting

4. COMPETITIVE LANDSCAPE

Competitive Landscape

  • 1. Competitive Landscape-Human Plasma-derived Therapeutics: Marketed Products
  • 2. Competitive Landscape-Human Plasma-derived Therapeutics Market: Pipeline Products
  • 3. Competitive Landscape-Count of Marketed and Pipeline Products
  • 4. Competitive Landscape-Key Clinical Trials

5. MARKETED PRODUCT ANALYSIS

Marketed Product Analysis

  • 1. Marketed Products Synopsis-Albumin
  • 2. Marketed Products Synopsis-Other Haematologicals
  • 3. Marketed Products Synopsis-Other Haematologicals (continued)
  • 4. Marketed Products Synopsis-Coagulation Factors
  • 5. Marketed Products Synopsis-Coagulation Factors (continued)
  • 6. Marketed Products Synopsis-Coagulation Factors (continued)
  • 7. Marketed Products Synopsis-Coagulation Factors (continued)
  • 8. Marketed Products Synopsis-Immunoglobulins
  • 9. Marketed Products Synopsis-Immunoglobulins (continued)
  • 10. Marketed Products Synopsis-Immunoglobulins (continued)
  • 11. Marketed Products Synopsis-Immunoglobulins (continued)
  • 12. Marketed Products Synopsis-Immunoglobulins (continued)
  • 13. Marketed Products Synopsis-Immunoglobulins (continued)

6. PIPELINE PRODUCT ANALYSIS

Pipeline Product Analysis

  • 1. Pipeline Analysis-Approved
  • 2. Pipeline Analysis-Phase 3
  • 3. Pipeline Analysis-Phase 3 (continued)
  • 4. Pipeline Analysis-Phase 2
  • 5. Pipeline Analysis-Phase 1

7. PRODUCT DASHBOARD

Product Dashboard

  • 1. Product Dashboard-ResusixTM, Entegrion, Inc.
  • 2. Product Dashboard-CINRYZE® (new formulation), Shire
  • 3. Product Dashboard-BIOSTATE® (new formulation), CSL Behring
  • 4. Product Dashboard-Gammagard, Baxter

8. CONCLUSIONS AND RECOMMENDATIONS

Conclusions and Recommendations

  • 1. Conclusions and Recommendations
  • 2. Legal Disclaimer

9. APPENDIX

Appendix

  • 1. Plasma-Overview
  • 2. Plasma-Overview (continued)

10. THE FROST & SULLIVAN STORY

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition-Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top